CADAS138 presents itself as a novel therapeutic target in the realm of neurodegenerative diseases. Preclinical studies demonstrate significant potential for CADAS138-targeted therapies to alleviate disease https://brendarczs958184.activoblog.com/49929603/a-novel-therapeutic-target